Unbiased RNAi screen for hepcidin regulators links hepcidin suppression to proliferative Ras/RAF and nutrient-dependent mTOR signaling
Open accessThe DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.
Abstract
The hepatic hormone hepcidin is a key regulator of systemic iron metabolism. Its expression is largely regulated by 2 signaling pathways: the "iron-regulated" bone morphogenetic protein (BMP) and the inflammatory JAK-STAT pathways. To obtain broader insights into cellular processes that modulate hepcidin transcription and to provide a resource to identify novel genetic modifiers of systemic iron homeostasis, we designed an RNA interference (RNAi) screen that monitors hepcidin promoter activity after the knockdown of 19 599 genes in hepatocarcinoma cells. Interestingly, many of the putative hepcidin activators play roles in signal transduction, inflammation, or transcription, and affect hepcidin transcription through BMP-responsive elements. Furthermore, our work sheds light on new components of the transcriptional machinery that maintain steady-state levels of hepcidin expression and its responses to the BMP- and interleukin-6-triggered signals. Notably, we discover hepcidin suppression mediated via components of Ras/RAF MAPK and mTOR signaling, linking hepcidin transcriptional control to the pathways that respond to mitogen stimulation and nutrient status. Thus using a combination of RNAi screening, reverse phase protein arrays, and small molecules testing, we identify links between the control of systemic iron homeostasis and critical liver processes such as regeneration, response to injury, carcinogenesis, and nutrient metabolism.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“An RNAi screen identified sorafenib, wortmannin, rapamycin and metformin as inducers of hepcidin mRNA expression (Mleczko-Sanecka et al., 2014).”
From Pharmacological Targeting of the Hepcidin/Ferroportin Axis (2016) · cites this paper as Mleczko-Sanecka et al., 2014
Citations
Cites
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Huang, D. W., Sherman, B. T., & Lempicki, R. A. (2009) · Nature Protocols · doi:10.1038/nprot.2008.211 · Cited by 35,890
Sorafenib in advanced hepatocellular carcinoma
Llovet, J. M., Ricci, S., Mazzaferro, V., Hilgard, P., Gane, E., Blanc, J.-F., de Oliveira, A. C., Santoro, A., Raoul, J.-L., Forner, A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708857 · Cited by 13,097
mTOR Signaling in Growth Control and Disease
Laplante, M., & Sabatini, D. M. (2012) · Cell · doi:10.1016/j.cell.2012.03.017 · Cited by 8,509 · cited 3×
“In the liver it plays a critical role for the maintenance of glucose and lipid homeostasis.(49) Because of the nutrient overload associated with obesity and type 2 diabetes, the activity of mTOR signaling is elevated.”
BackgroundSorafenib in Advanced Hepatocellular Carcinoma
정, 재. (2008) · Cited by 5,586
Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization
Nemeth, E., Tuttle, M. S., Powelson, J., Vaughn, M. B., Donovan, A., Ward, D. M., Ganz, T., & Kaplan, J. (2004) · Science · doi:10.1126/science.1104742 · Cited by 4,803 · cited 1×
“Hepcidin binds to ferroportin, the iron efflux channel predominantly expressed on iron-exporting cells, causing its internalization and degradation.(2) Conditions of high iron load or inflammation activate hepcidin production in the liver to reduce serum iron levels, whereas iron deficiency, hypoxia, and augmented ery…”
BackgroundSzklarczyk, D., Franceschini, A., Kuhn, M., Simonovic, M., Roth, A., Minguez, P., Doerks, T., Stark, M., Muller, J., Bork, P., et al. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq973 · Cited by 3,460 · cited 2×
“To search for functional relationships among the putative hepcidin regulators, we performed bioinformatic analyses using the software tools DAVID(44) and STRING.(45) DAVID analysis identified 193 enriched functional terms among the putative hepcidin activators (supplemental Table 5 and supplemental File 2).”
MethodNemeth, E., Rivera, S., Gabayan, V., Keller, C., Taudorf, S., Pedersen, B. K., & Ganz, T. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420945 · Cited by 2,650
Integration of biological networks and gene expression data using Cytoscape
Cline, M. S., Smoot, M., Cerami, E., Kuchinsky, A., Landys, N., Workman, C., Christmas, R., Avila-Campilo, I., Creech, M., Gross, B., et al. (2007) · Nature Protocols · doi:10.1038/nprot.2007.324 · Cited by 2,507
Two to tango: Regulation of Mammalian iron metabolism
Hentze, M. W., Muckenthaler, M. U., Galy, B., & Camaschella, C. (2010) · Cell · doi:10.1016/j.cell.2010.06.028 · Cited by 2,120 · cited 2×
“Conditions of high iron load or inflammation activate hepcidin production in the liver to reduce serum iron levels, whereas iron deficiency, hypoxia, and augmented erythropoiesis inhibit hepcidin expression to increase systemic iron availability.(1) Most iron-related disorders are attributed to excessive or inadequate…”
BackgroundSelf-citationGEFs and GAPs: Critical Elements in the Control of Small G Proteins
Bos, J. L., Rehmann, H., & Wittinghofer, A. (2007) · Cell · doi:10.1016/j.cell.2007.05.018 · Cited by 1,903 · cited 1×
“Importantly, two of the identified hepcidin modifiers, RASA1 and RASAL2, directly connect to Ras protein inactivation.(41,61,62) Our observation that systemic loss of Rasa1 in the mouse affects liver hepcidin expression further indicates that regulators of Ras activity may function as modifiers of iron homeostasis in…”
Background
Research works printed but not linked: 1
- Latour, 2013, Testosterone perturbs systemic iron balance through activation of EGFR signaling in the liver and repression of hepcidin [published online ahead of print August 1, 2013]., Hepatology
Cited by
A Red carpet for iron metabolism
Muckenthaler, M. U., Rivella, S., Hentze, M. W., & Galy, B. (2017) · Cell · doi:10.1016/j.cell.2016.12.034 · Cited by 1,319
Self-citationBiomarkers of Nutrition for Development—Folate Review
Bailey, L. B., Stover, P. J., McNulty, H., Fenech, M. F., Gregory, J. F., Mills, J. L., Pfeiffer, C. M., Fazili, Z., Zhang, M., Ueland, P. M., et al. (2015) · The Journal of Nutrition · doi:10.3945/jn.114.206599 · Cited by 1,136
Biomarkers of Nutrition for Development (BOND)—Iron Review
Lynch, S., Pfeiffer, C. M., Georgieff, M. K., Brittenham, G., Fairweather-Tait, S., Hurrell, R. F., McArdle, H. J., & Raiten, D. J. (2018) · The Journal of Nutrition · doi:10.1093/jn/nxx036 · Cited by 336
“Recent studies have found that yet other signal transduction pathways are involved in the control of hepcidin synthesis, including mammalian target of rapamycin (mTOR) and proliferative rat sarcoma/rapidly accelerated fibrosarcoma mitogen-activated protein kinase (RAS/RAF MAPK) signaling, linking hepcidin regulation t…”
BackgroundHepcidin regulation in the anemia of inflammation
Wang, C.-Y., & Babitt, J. L. (2016) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000236 · Cited by 250
The Iron age of host–microbe interactions
Soares, M. P., & Weiss, G. (2015) · The EMBO Reports · doi:10.15252/embr.201540558 · Cited by 227
“The mechanisms underlying this effect have not been entirely elucidated, but involve the transcription factors hypoxia-inducible factor 1 a (HIF1 a ) nuclear factor for IL-6 expression (NF-IL6) and STAT and likewise phospho-kinase-controlled pathways [164 – 167].”
Metadata
- Authors
- Mleczko-Sanecka, K., Roche, F., Rita da Silva, A., Call, D., D’Alessio, F., Ragab, A., Lapinski, P. E., Ummanni, R., Korf, U., Oakes, C., Damm, G., D’Alessandro, L. A., Klingmüller, U., King, P. D., Boutros, M., Hentze, M. W., & Muckenthaler, M. U.
- Affiliations
- Department of Pediatric Oncology, Hematology and Immunology, and
- Heidelberg University (DE)
- German Cancer Research Center (DE)
- University of Michigan (US)
- Charité – Universitätsmedizin Berlin (DE)
- ORCID
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2014-03-06
- Volume
- 123
- Issue
- 10
- Pages
- 1574-1585
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- PMC
- PMC3945866
- OpenAlex
- W2146277667
- Cited by
- 74
- References
- 76
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 5 · 2023: 7 · 2022: 5 · 2021: 9 · 2020: 4 · 2019: 3 · 2018: 6 · 2017: 10 · 2016: 4 · 2015: 7 · 2014: 10
- FWCI
- 7.33
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Blood (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (R01HL096498)
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Ferroptosis and cancer prognosis
- Life Sciences › Agricultural and Biological Sciences › Plant Science › Plant Micronutrient Interactions and Effects
- Keywords
- hepcidin, iron homeostasis, BMP signaling, JAK/STAT signaling, Ras/Raf/MAPK signaling, mTOR signaling, nutrient signaling, hepatocellular carcinoma cells, RNAi screen, interleukin-6, liver regeneration, carcinogenesis
- MeSH terms
- Animals, Cell Line, Gene Expression Regulation, Humans, Male, Protein Binding, Transcription, Genetic, Reproducibility of Results, Signal Transduction, Proto-Oncogene Proteins p21(ras), Mice, Knockout, Bone Morphogenetic Proteins, Proto-Oncogene Proteins c-raf, Response Elements, Gene Expression Profiling, Mitogen-Activated Protein Kinases, RNA Interference, Mice, TOR Serine-Threonine Kinases, Hepcidins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Unbiased RNAi screen for hepcidin regulators links hepcidin suppression to proliferative Ras/RAF and nutrient-dependent mTOR signaling. https://app.cochat.ai/papers/10.1182/blood-2013-07-515957
- The paper
- Mleczko-Sanecka, K., Roche, F., Rita da Silva, A., Call, D., D’Alessio, F., Ragab, A., Lapinski, P. E., Ummanni, R., Korf, U., Oakes, C., Damm, G., D’Alessandro, L. A., Klingmüller, U., King, P. D., Boutros, M., Hentze, M. W., & Muckenthaler, M. U. (2014). Unbiased RNAi screen for hepcidin regulators links hepcidin suppression to proliferative Ras/RAF and nutrient-dependent mTOR signaling. Blood. https://doi.org/10.1182/blood-2013-07-515957
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.